论文部分内容阅读
肺结核的初次治疗病例,据认为治疗时间是可以缩短的。特别是在RFP出现以后,欧洲、非洲、印度和香港地区相继报道了6个月、9个月甚至3个月的治疗效果。可是,据日本结核病临床医师报道,经过3个月或6个月的治疗,多数病例均产生特别强的耐药性和复发,尤其是痰菌阳性病例,尽管施行6个月或9个月治疗后,包括继续使用INH或INH+a治疗,也会发生上述现象。因此,必须寻求或探索其适当的治疗方法及期限。本文仅根据我院的实际调查。就以下几个问题进行讨论:(1)关于治疗短期化,短期强化治疗的期限,(2)短期强
The first treatment of tuberculosis cases, it is believed that the treatment time can be shortened. Especially after the emergence of RFP, the treatment effects of 6 months, 9 months and even 3 months have been reported successively in Europe, Africa, India and Hong Kong. However, according to Japanese tuberculosis clinicians, most cases develop particularly strong resistance and relapse after 3 or 6 months of treatment, especially sputum-positive cases, despite the 6-month or 9-month treatment This can also happen when you continue including INH or INH + a treatment. Therefore, we must seek or explore its appropriate treatment methods and deadlines. This article is based on the actual investigation of our hospital. Discussion on the following issues: (1) on the treatment of short-term, short-term intensive treatment, (2) short-term strong